CCR5 promoter polymorphism and HIV-1 disease progression
Open Access
- 1 September 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 352 (9131), 866-870
- https://doi.org/10.1016/s0140-6736(98)04158-0
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- Emory University (RR00165)
- National Cancer Institute
- Yerkes Regional Primate Research Center
This publication has 25 references indexed in Scilit:
- Genetic Restriction of AIDS Pathogenesis by an SDF-1 Chemokine Gene VariantScience, 1998
- Novel Alleles of the Chemokine-Receptor Gene CCR5American Journal of Human Genetics, 1997
- Risk of Mother-to-Infant Transmission of HIV-1 Is Not Reduced in CCR5/Δ32ccr5 HeterozygotesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- CCR5-Δ32 gene deletion in HIV-1 infected patientsThe Lancet, 1997
- Unwelcomed Guests with Master Keys: How HIV Uses Chemokine Receptors for Cellular EntryVirology, 1997
- Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease ProgressionScience, 1997
- The extent of genetic variation in the CCR5 geneNature Genetics, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- A Receptor for the Malarial Parasite Plasmodium vivax : the Erythrocyte Chemokine ReceptorScience, 1993